Track Envista Holdings Corporation — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Envista Holdings Corporation NVST · Stock Open Envista Holdings Corporation in new tab

27.37 USD
P/E
65.51
EPS
0.41
P/B
1.42
ROE
2.21
Beta
0.86
Target Price
29.43 USD
Loading chart...
Key Metrics
Earnings dateAug. 5, 2026
P/E65.51
EPS0.41
Book Value18.90
Price to Book1.42
Debt/Equity51.61
% Insiders0.480%
Growth
Revenue Growth0.14%
Earnings Growth1.30%
Estimates
Forward P/E17.07
Forward EPS1.57
Target Mean Price29.43

DCF Valuation

Tweak assumptions to recompute fair value for Envista Holdings Corporation (NVST)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Envista Holdings Corporation Logo Envista Holdings Corporation Analysis (NVST)

United States Health Care Official Website Stock

Is Envista Holdings Corporation a good investment? Envista Holdings Corporation (NVST) is currently trading at 27.37 USD. Market analysts have a consensus price target of 29.43 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 65.51. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Envista Holdings Corporation is expected to release its next earnings report on Aug. 5, 2026. The market consensus estimate for Forward EPS is 1.57.

Investor FAQ

Does Envista Holdings Corporation pay a dividend?

No, it does not currently pay a dividend.

What asset class is Envista Holdings Corporation?

Envista Holdings Corporation is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Aug. 5, 2026. The company currently has a trailing EPS of 0.41.

Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Exchange Ticker
VAN (Canada) CLZ.V
FRA (Germany) 0HV.F
NYQ (United States) NVST
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion